Call for Anjani Mashelkar Inclusive Innovation Award nominations announced

2018-06-18 08:48:46

The Anjani Mashelkar Inclusive Innovation Award is an annual award of Rs. 1 lakh given to an individual or an organization for an idea, prototype or a commercialized product, service and business model.By Team ABLEThe Anjani Mashelkar Inclusive Innovation Award is an annual award of Rs. 1 lakh given to an individual or an organization for an idea, prototype or a commercialized product, service and

Read more

Scientists crack faster genome evolution methods to transform yeast for industrial biotechnology

2018-06-18 08:47:52

The discovered system allows researchers to reshuffle the deck of cards for the genome, and customize new yeast strains that can recombine on demand with each other to generate novel genome combinations not found in nature before.By Team ABLEScientists have created a new way of speeding up the genome evolution of baker\'s yeast Saccharomyces cerevisiae, the same yeast people use for bread and beer

Read more

Bayer closes Monsanto acquisition

2018-06-15 13:24:24

According to the conditional approval from the United States Department of Justice, the integration of Monsanto into Bayer can take place as soon as the divestments to BASF have been completed.By Team ABLEBayer successfully completed the acquisition of Monsanto on June 7th, 2018. The press statement clearly states that the shares in the U.S. company will no longer be traded on the New York Stock E

Read more

Union Minister J P Nadda releases accelerated plan for elimination of Lymphatic Filariasis

2018-06-15 13:23:13

The strategy to eliminate Lymphatic Filariasis in India is based on twin pillars of Mass Drug Administration (MDA) once in a year. By Team ABLERecently, Union Minister of Health and Family Welfare J P Nadda inaugurated the 10th meeting of Global Alliance to Eliminate Lymphatic Filariasis (GAELF) at New Delhi. During his inaugural address, Shri Nadda said that India as a Global leader is committed

Read more

Cabinet approves MoU between the ICMR and INSERM, France

2018-06-15 13:10:08

The MoU aims at cooperation in areas of common interest within the medical, life sciences and health research fields.By Team ABLEThe Union Cabinet chaired by the Prime Minister Shri Narendra Modi has been apprised of a Memorandum of Understanding (MoU) which was signed in March, 2018 between the Indian Council of Medical Research (ICMR) and the Institut National de la Santeet de la RechercheMedica

Read more

Cabinet approves Three Year Action Plan of Agricultural Education Division & ICAR Institutes

2018-06-15 13:08:49

The approved scheme is aimed to generate quality human resources from the institutions of higher agricultural education.By Team ABLEThe Union Cabinet chaired by Prime Minister Shri Narendra Modi has approved the continuation of the Three Year Action Plan (2017-2020) of the scheme for Agricultural Education Division and ICAR Institutes with an outlay of Rs.2225.46 crore [Rs. 2197.51 crore + Rs. 27.

Read more

US FDA approves DyAnsys’ wearable medical device to treat drug addiction

2018-06-13 09:40:37

The U.S. Food and Drug Administration has cleared an auricular neurostimulation device manufactured by a Chennai company to treat the symptoms of opioid withdrawal without narcotics.By Team ABLEThe U.S. Food and Drug Administration has cleared an auricular neurostimulation device manufactured by a Chennai company to treat the symptoms of opioid withdrawal without narcotics. The device, Drug Relief

Read more

Merck’s ethical gene editing considerations published in Bioethics Journal

2018-06-13 09:39:35

The American Journal of Bioethics has accepted Merck’s publication on ethical issues in genome editing to be printed in its July issue. A summary version has been published in The American Journal of Bioethics blog.By Team ABLEMerck, a leading science and technology company and leader in genome editing, has announced that The American Journal of Bioethics has accepted a publication on ethical is

Read more

AstraZeneca, Eli Lilly to discontinue Alzheimer’s disease drug lanabecestat’s trials

2018-06-13 09:38:25

Independent data monitoring committee has advised the companies that lanabecestat is unlikely to meet primary endpoints, hence leading to a decision to discontinue these trials. By Team ABLEAstraZeneca and Eli Lilly and Company (Lilly) have announced today that the companies are discontinuing the global Phase III clinical trials of lanabecestat, an oral beta secretase cleaving enzyme (BACE) inhibi

Read more

Trump’s ‘Right to Try’ Legislation could boost orphan drug market in US: Kalorama report

2018-06-13 09:37:18

The legislation authorizes doctors to prescribe drugs that have cleared first phase but have not been through human clinical trials and thus not yet been approved by the Food and Drug Administration. By Team ABLEMarket Research firm Kalorama Information said that recently signed legislation to give terminally ill patients the right to use experimental medications could boost the market for orphan

Read more